Skip to content
Medical Health Aged Care

New Cleanbill data reflects cost pressures on general practice care: RACGP

Royal Australian College of GPs 2 mins read

New data from Cleanbill highlights the cost pressures on general practice which are forcing up out-of-pocket costs for patients, says the Royal Australian College of GPs (RACGP). 

The independent Cleanbill 2024 Blue Report released today shows average out-of-pocket costs have increased in every state and territory to over $40. And the number of practices bulk billing all patients also continued to decline – 514 clinics which bulk billed all patients at the start of 2023 had stopped by November. 

RACGP President Dr Nicole Higgins said it’s further evidence of the need to do more to ensure everyone can access affordable care. 

“This report shows we need to do more to address the rising costs for care in Australia – patient financial issues was also one of the top concerns GPs reported in our 2023 Health of the Nation,” she said. 

“While the government’s tripling of bulk billing incentives has helped more GPs bulk bill specific groups, including children, pensioners, and healthcare card holders, more needs to be done to ensure care is affordable for the rest of the population. 

“This situation is a direct result of the 10-year freeze on patient Medicare rebates. This ripped funding from general practice, so now even though more people access general practice than any other health service, it gets just 6.5% of the total government spend on healthcare. Practices are also facing the same inflationary pressures as other businesses. 

“On top of all that, in many states practices are having to raise patient out-of-pocket fees to cover the costs of an extra state payroll tax on independent practitioners. While practices have always paid payroll tax on their employees, it never applied to GPs because they work under independent agreements, but this changed after a new interpretation of payroll tax law. 

“So far Queensland is the only state which has issued a new Revenue Ruling stating patients’ fees paid directly to a GP won’t be subject to payroll tax, and we’re continuing to call for other states and territories to do the same. We’re also calling for no retrospective tax collection because this will force practices to close – at least 184 practices closed last year, we can’t afford to lose any more. 

“It’s absolutely vital that everyone can afford general practice care – it helps people live healthier lives and reduces pressure on our hospitals. It’s also our most cost-effective health service, with a 20-minute GP consult costing around $40, whereas a visit to hospital costs over $600, and much more if a patient is admitted. 

“The government knows action is needed and they’ve committed to rebuilding Medicare and general practice. While there’s no quick fix, we do need to keep up the momentum to secure the financial sustainability of general practice, enable bulk billing for those who need it, and ensure GP care is affordable for everyone.” 

~ENDS

 


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992media@racgp.org.au

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 12/11/2024
  • 17:26
Merck

Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial

Phase III MANEUVER study met primary endpoint, with an objective response rate at week 25 of 54.0% for pimicotinib versus 3.2% for placebo (p<0.0001)…

  • Contains:
  • Medical Health Aged Care
  • 12/11/2024
  • 17:00
Scarecrow Incorporated

World’s First Patent Acquired for Animal Supplement “Pinfenon” (S) (R)

TOKYO, Nov. 12, 2024 /Kyodo JBN/ -- - Patent Covers Invention of Treatment Drug and Prophylactic Drug for Lowering Cardiac Disorder Markers in Dogs as Well as Their Manufacturing Methods - Scarecrow Incorporated, based in Tokyo's Shibuya Ward, is pleased to announce that it has acquired the world's first (*) patent for Pinfenon (S) (R), an animal supplement made in Japan, associated with a treatment drug and a prophylactic drug for lowering the atrial natriuretic peptide (ANP) as well as their manufacturing methods. The supplements approved as drugs by the Japan Patent Office are subject to technical transfer in such…

  • Business Company News, Medical Health Aged Care
  • 12/11/2024
  • 10:00
Jane Morgan Management

LTR Pharma Ltd (ASX:LTP) Announces Joint Venture with Leading Men’s Health Group to Launch New Online Healthcare Platform

Sydney, Australia – 12 November 2024 | LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce its new strategic joint venture with the Restorative Sexual Health Clinic Pty Ltd (RSHC), a prominent Australian men’s health group, to launch an online healthcare platform dedicated to men’s health. The platform will provide accessible, comprehensive health services, including medical consultations, therapeutic services, prescription treatments, and integrated health management solutions. Highlights: Strategic Partnership/Joint Venture: The joint venture combines LTR Pharma’s pharmaceutical expertise with RSHC’s clinical experience in the men’s health space to create a digital platform offering discreet and convenient…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.